phosphatidylcholine 36:2 (CHEBI:64433)

ChEBI > Main

Main

ChEBI Ontology

Automatic Xrefs

Reactions

Pathways

Models

ChEBI Name	phosphatidylcholine 36:2

ChEBI ID	CHEBI:64433

Definition	A 1,2-diacyl-sn-glycero-3-phosphocholine in which the acyl groups at C-1 and C-2 contain 36 carbons in total and 2 double bonds.

Stars	This entity has been manually annotated by the ChEBI Team.

Download	Molfile XML SDF

Formula

C44H84NO8P

Net Charge

Average Mass (excl. R groups)

786.11340

Monoisotopic Mass (excl. R groups)

785.59346

SMILES

[H][C@@](COC(C)=O)(COP([O-])(=O)OCC[N+](C)(C)C)OC(C)=O

Roles Classification
Biological Role(s):	metabolite Any intermediate or product resulting from metabolism. The term 'metabolite' subsumes the classes commonly known as primary and secondary metabolites.

ChEBI Ontology
Outgoing	phosphatidylcholine 36:2 (CHEBI:64433) has role metabolite (CHEBI:25212) phosphatidylcholine 36:2 (CHEBI:64433) is a 1,2-diacyl-sn-glycero-3-phosphocholine (CHEBI:57643)

Incoming	1,2-di-octadecenoyl-sn-glycero-3-phosphocholine (CHEBI:84836) is a phosphatidylcholine 36:2 (CHEBI:64433) 1-[(9Z,12Z)-octadecadienoyl]-2-octadecanoyl-sn-glycero-3-phosphocholine (CHEBI:86112) is a phosphatidylcholine 36:2 (CHEBI:64433) 1-octadecanoyl-2-[(10Z,12Z)-octadecadienoyl]-sn-glycero-3-phosphocholine (CHEBI:84819) is a phosphatidylcholine 36:2 (CHEBI:64433) 1-octadecanoyl-2-[(2E,4E)-octadecadienoyl]-sn-glycero-3-phosphocholine (CHEBI:84820) is a phosphatidylcholine 36:2 (CHEBI:64433) 1-octadecanoyl-2-[(6Z,9Z)-octadecadienoyl]-sn-glycero-3-phosphocholine (CHEBI:84821) is a phosphatidylcholine 36:2 (CHEBI:64433) 1-octadecanoyl-2-[(9Z,12Z)-octadecadienoyl]-sn-glycero-3-phosphocholine (CHEBI:84822) is a phosphatidylcholine 36:2 (CHEBI:64433) 1-palmitoyl-2-(11Z,14Z-eicosadienoyl)-sn-glycero-3-phosphocholine (CHEBI:84574) is a phosphatidylcholine 36:2 (CHEBI:64433) PC(18:1_18:1) (CHEBI:167257) is a phosphatidylcholine 36:2 (CHEBI:64433) phosphatidylcholine (18:0/18:2) (CHEBI:136063) is a phosphatidylcholine 36:2 (CHEBI:64433)

Citation	Type	Source
19347970	PubMed citation	Europe PMC

Last Modified

23 February 2017